Press Releases

Date	Title
2/3/21	Pulse Biosciences Announces FDA Clearance for the CellFX® System
1/25/21	Pulse Biosciences Announces CE Mark Approval for CellFX® System
1/12/21	Pulse Biosciences Updates on CellFX System Regulatory and Clinical Study Progress
1/5/21	Pulse Biosciences, Inc. Announces Redemption of Warrants
12/15/20	Pulse Biosciences Grants Equity Incentive Awards To New Employees
12/4/20	Pulse Biosciences Presents Update on Nano-Pulse Stimulation™ Technology at Prestigous Energy-Based Devices and Aesthetic Dermatology Conference
11/11/20	Pulse Biosciences to Participate in Upcoming Investor Conferences
11/9/20	Pulse Biosciences Reports Third Quarter 2020 Financial Results
10/28/20	Pulse Biosciences Schedules Third Quarter 2020 Financial Results Conference Call for November 9, 2020
10/7/20	Pulse Biosciences Announces Presentation of Clinical Results Using Nano-Pulse Stimulation Technology for the Clearance of Skin Lesions at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting

Keyword Search